home.aspx
 
. https://pharmaceutical.report/Resources/Whitepapers/a0624165-7ee2-4bd1-835b-145450d62b72_White-Paper-DSCSA-Compliance-and-Pharmaceutical-3PL-Providers-082616-with-release-edited-
whitepaper
SHARESHARESHARE
DSCSA IMPLEMENTATION FOR PHARMACEUTICAL 3PL PROVIDERS
With the stroke of a pen in 2013, the pharmaceutical industry mobilized in order to comply with sweeping changes enacted by the Drug Quality and Safety Act. The law includes the Drug Supply Chain Security Act (“DSCSA”), written to increase patient safety by minimizing risk from unauthorized pharmaceutical drug products entering the marketplace. The Federal Drug Administration, charged with enforcing the Act, set deadlines for the industry to comply with this law. The law requires all companies within the pharmaceutical supply chain to develop an electronic system designed to increase patient safety by minimizing drug diversion and reducing counterfeit products. The FDA set a deadline of November 2017 for companies to be in compliance with the law. Pharmaceutical manufacturers that do not confirm their supply chain is DSCSA-compliant before the deadline risk affecting patient health and may face regulatory penalties. DOWNLOAD